List of COVID-19 vaccine authorizations
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.
For COVID-19 vaccination policy by country, see Vaccination policy § Table.
Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi–GSK.[1] Seven others are under assessment by the WHO: Sputnik V, Sinopharm WIBP, Abdala, Zifivax, Corbevax, COVIran Barekat, and SCB-2019.[2]
Of the 40 vaccines, 16 have a full or emergency authorization in only one country, 12 in ten or fewer countries, and 12 in more than ten countries.
Note that in some countries, vaccines may be authorized solely for travel purposes. They may not be approved for the general population. For example, the CoronaVac, Covishield, BBIBP-CorV and Covaxin vaccines are not part of Australia's national vaccination program; however, they are recognized for the purpose of travel to Australia.[3][4][5]
The CoronaVac COVID-19 vaccine is an inactivated virus vaccine[590] produced by the Chinese company Sinovac Biotech.[590][591][592]
Non-country entities
VLA2001 is an inactivated vaccine developed by Valneva SE and Dynavax Technologies.
Sputnik Light is a viral vector vaccine,[701] produced by the Russian Gamaleya Research Institute of Epidemiology and Microbiology. It consists of the first dose of the Sputnik V vaccine, which is based on the Ad26 vector.[702]
Convidecia is a viral vector vaccine[727] produced by the Chinese company CanSino Biologics and the Beijing Institute of Biotechnology of the Academy of Military Medical Sciences.
Non-country entities
The Sinopharm WIBP COVID-19 vaccine is an inactivated virus vaccine produced by the China National Pharmaceutical Group (Sinopharm) and its Wuhan Institute of Biological Products.
Abdala is a subunit vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba.
EpiVacCorona is a peptide vaccine produced by the Russian State Research Center of Virology and Biotechnology VECTOR.[749]
Zifivax is a subunit vaccine produced by the Chinese company Anhui Zhifei Longcom Biopharmaceutical.[755]
Soberana 02, is a conjugate vaccine developed by the Finlay Institute in Cuba.[761]
CoviVac is an inactivated virus vaccine[701] produced by the Chumakov Centre at the Russian Academy of Sciences.[765]
QazCovid-in, also known as QazVac, is an inactivated virus vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan.[768]
Minhai COVID-19 vaccine, is an inactivated virus vaccine developed by Minhai Biotechnology Co. and Shenzhen Kangtai Biological Products Co. Ltd. in China.[772]
MVC-COV1901, is a protein subunit vaccine developed by Taiwan's Medigen Vaccine Biologics and Dynavax Technologies.[774]
1. Somaliland[776]
Corbevax is a protein subunit vaccine developed by Texas Children's Hospital at the Baylor College of Medicine in Houston, Texas, and licensed to Indian biopharmaceutical firm Biological E. Limited (BioE) for development and production.[661][780]
COVIran Barekat, is an inactivated virus vaccine developed by Shifa Pharmed Industrial Co. in Iran.[782]
ZyCoV-D, is a DNA plasmid based COVID-19 vaccine developed by the Indian pharmaceutical company Cadila Healthcare with support from the Biotechnology Industry Research Assistance Council.[787]
FAKHRAVAC (or MIVAC), is an inactivated virus vaccine developed in Iran by the Organization of Defensive Innovation and Research, an organization of Iran's Ministry of Defense.[788]
COVAX-19, also known as SpikoGen, is a protein subunit vaccine jointly developed by Australian-based company Vaxine and Iran-based company CinnaGen.[789]
Razi Cov Pars is a protein subunit vaccine developed by Razi Vaccine and Serum Research Institute.[790]
Turkovac is an inactivated vaccine developed by Health Institutes of Turkey and Erciyes University.[791]
Sinopharm CNBG COVID-19 vaccine (NVSI) is a recombinant protein subunit vaccine developed by the National Vaccine & Serum Institute (NVSI, 中生研究院), a subsidiary of China National Biotec Group (CNBG), which in turn is a subsidiary of Sinopharm.[792]
Soberana Plus is a single-dose of conjugate vaccine developed by the Finlay Institute in Cuba.[793]
CoVLP is a virus-like particle vaccine grown in an Australian weed, Nicotiana benthamiana. It was developed by Medicago, and is marketed under the name Covifenz Archived 24 February 2022 at the Wayback Machine.
Noora is a protein-based vaccine developed by the Baqiyatallah University of Medical Sciences.